Stockscreener 앱 받기
0.4118
2.56%
-0.0108
시간 외 거래:
.42
0.0082
+1.99%
전일 마감가:
$0.4226
열려 있는:
$0.41
하루 거래량:
174.95K
Relative Volume:
0.91
시가총액:
$634.75K
수익:
$743.00K
순이익/손실:
$-7.63M
주가수익비율:
-0.1373
EPS:
-3
순현금흐름:
-
1주 성능:
-13.29%
1개월 성능:
-33.58%
6개월 성능:
-63.40%
1년 성능:
-80.94%
1일 변동 폭
$0.4065
$0.42
1주일 범위
$0.4065
$0.4814
52주 변동 폭
$0.4065
$2.50
캔 파이트 바이오파마 Stock (CANF) Company Profile
명칭
Can-Fite Biopharma Ltd ADR
전화
972 3 924 1114
주소
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
CANF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CANF
Can-Fite Biopharma Ltd ADR
|
0.4118 | 7.22M | 743.00K | -7.63M | 0 | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
캔 파이트 바이오파마 Stock (CANF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-10-19 | 재개 | ROTH Capital | Buy |
| 2016-08-29 | 재개 | Rodman & Renshaw | Buy |
| 2015-11-30 | 재확인 | H.C. Wainwright | Buy |
| 2015-03-31 | 재확인 | H.C. Wainwright | Buy |
| 2015-03-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-29 | 재확인 | ROTH Capital | Buy |
| 2014-11-18 | 개시 | H.C. Wainwright | Buy |
모두보기
캔 파이트 바이오파마 주식(CANF)의 최신 뉴스
Will Can Fite Biopharma Ltd Sponsored ADR stock see insider accumulation2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Can Can Fite Biopharma Ltd Sponsored ADR stock deliver double digit returnsGlobal Markets & Daily Price Action Insights - newser.com
How big funds are accumulating Can Fite Biopharma Ltd Sponsored ADR stockTrade Ideas & Weekly Top Gainers Trade List - newser.com
Why retail traders accumulate Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Will Can Fite Biopharma Ltd Sponsored ADR stock benefit from mergersMarket Sentiment Report & Real-Time Volume Spike Alerts - fcp.pa.gov.br
Why Can Fite Biopharma Ltd Sponsored ADR stock could rally stronglyJuly 2025 Technicals & Free Community Supported Trade Ideas - fcp.pa.gov.br
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong analyst pickQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong buy callTake Profit & Verified Momentum Stock Ideas - newser.com
Will Can Fite Biopharma Ltd Sponsored ADR stock beat growth indexesJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock could outperform next yearGlobal Markets & Weekly Return Optimization Alerts - newser.com
Why pension funds invest in Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock fits value portfolios2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock expanding market penetration2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock a contrarian opportunityEarnings Miss & Real-Time Volume Triggers - newser.com
캔 파이트 바이오파마 (CANF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):